The filing reports insider equity awards for Rashida La Lande, Executive Vice President & General Counsel of The Estée Lauder Companies Inc. (EL). On 08/28/2025 Ms. La Lande was awarded 11,487 restricted stock units (RSUs) vesting in three equal installments beginning 11/02/2026, 11,388 non-annual RSUs vesting on 11/01/2027, and stock options covering 44,170 shares with exercise price $91.77 that vest in three tranches beginning 11/02/2026 and expire 08/28/2035. RSUs pay out one-for-one in Class A common shares and include cash dividend equivalents; shares may be withheld for taxes. The Form 4 was signed by attorney-in-fact on 09/02/2025.
Jane Hertzmark Hudis, Executive Vice President & Chief Brand Officer of The Estée Lauder Companies (EL) received equity awards on 08/28/2025 consisting of 20,475 restricted stock units vesting in three annual tranches beginning 11/02/2026, 20,297 restricted stock units vesting 11/01/2027, and 78,727 stock options with an exercise price of $91.77 and staggered exercisability beginning 11/02/2026 through 11/01/2028. RSUs pay out one-for-one in Class A common shares and include dividend equivalents; shares will be withheld at payout for taxes. The form is a Section 16 filing reporting these grants; all holdings are reported as direct beneficial ownership.
Lynn Forester de Rothschild, a director of The Estée Lauder Companies Inc. (EL), reported transactions on 08/29/2025. The filing shows exercise/acquisition of 3,972 shares at a weighted average price of $84.35 and the sale of 3,702 shares at prices ranging from $91.65 to $91.68. After these transactions the reporting person beneficially owned 15,479 shares of Class A common stock. The derivative section records that 3,972 stock options with an exercise price of $84.35 (granted 11/12/2016, expiring 11/12/2025) were exercised, and zero derivative securities remain beneficially owned. The form is signed by attorney-in-fact on 09/02/2025.
The filing reports a proposed sale by an insider of common stock in The Estée Lauder Companies Inc. The notice states 3,702 shares will be sold on or about 08/29/2025 on the NYSE, with an aggregate market value of $339,276.08 and total shares outstanding listed as 359,889,444. The shares were acquired the same day by stock option exercise and paid for in cash. The filer certifies they are not aware of undisclosed material adverse information about the issuer. No other sales in the past three months were reported.
Rashida La Lande, Executive Vice President & General Counsel of The Estée Lauder Companies Inc. (EL), reported equity activity tied to RSU vesting and related tax withholding. On 08/27/2025, 14,357 shares were issued upon payout of vested restricted stock units. Of those, 7,940 shares were withheld to satisfy tax obligations. On 08/28/2025, La Lande sold 6,417 shares in multiple open-market transactions at a weighted average price of $91.88 per share (sales ranged $91.88–$91.91). Following these transactions, the Form 4 reports 0 shares beneficially owned. Remaining non-annual RSUs granted 08/27/2024 will vest in two future installments of 14,357 shares each on 08/27/2026 and 08/27/2027, subject to continued employment.
The filer notifies of a proposed sale of 6,417 common shares of The Estée Lauder Companies Inc. The shares were acquired as restricted stock from the issuer on 08/27/2025 and the filer indicates an approximate sale date of 08/28/2025 through Morgan Stanley Smith Barney LLC, with an aggregate market value reported as $589,607.44. The filing shows 359,889,444 shares outstanding and states there were no sales by the filer in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Richard F. Zannino, a director of The Estée Lauder Companies Inc. (EL), reported exercising stock options on 08/25/2025. He acquired 3,972 Class A common shares by exercising options at a price of $84.35 per share. After the transaction he beneficially owns 12,159 shares indirectly through an LLC for which he has investment power. The options were granted under the companys Non-employee Director Share Incentive Plan and were previously transferred to the LLC; the options list an original exercisability date of 11/12/2016 and an expiration date of 11/12/2025. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
A family trust associated with Estee Lauder director Charlene Barshefsky exercised 3,972 stock options for Class A Common Stock at an exercise price of $84.35 per share and on August 22, 2025 sold 3,723 shares at $91.07 per share. The options were granted under the issuer’s Non-employee Director Share Incentive Plan and previously transferred to the trust. After these trades, a family trust holds 50,048.528 shares indirectly, with additional indirect holdings of 29,950 shares by a spousal family trust and 50 shares by her spouse.
Jane Lauder, a director and reported >10% owner of The Estée Lauder Companies Inc. (EL), reported transactions dated 08/21/2025. The filing shows acquisition of 15,699 stock options with an exercise price of $77.35, exercisable in three equal tranches (5,233 shares each) beginning 01/01/2017, 01/01/2018 and 01/01/2019. The filing also reports sales of 15,699 Class A common shares in multiple open-market transactions at a weighted average price of $88.23 (range $88.20–$88.35). Following these reported transactions, beneficial ownership is shown as 58,763 Class A shares, down from 74,462 prior to the transactions. The form is signed on behalf of Jane Lauder by an attorney-in-fact on 08/25/2025.
The filing reports a proposed sale of common stock of The Estée Lauder Companies, Inc. An individual exercised stock options and intends to sell 3,723 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $339,065.15. The securities were acquired by stock option exercise and payment was in cash on 08/22/2025. The filing lists total shares outstanding as 359,889,444, and notes no other sales in the past three months. The filer affirms they have no undisclosed material adverse information.